Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.258NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.349NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.314NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.132NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.99.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KT.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JC.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.334NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.359NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.302NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.222NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.434NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.467NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EE.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.72NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBJ.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CK.2.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EE.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DB.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BW.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KB.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-21208.1South Korea
HF.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BG.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.42.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.517NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17723.5South Korea
B.1.427 (Epsilon)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.429 (Epsilon)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.166NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.16.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.9.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.72NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.73NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDZNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XEBNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.263NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.180NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.31NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GB.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used